Clinical Trial

An Observational Study of Patients With Autoimmune Disease

Name: An Observational Study of Patients With Autoimmune Disease — clinical trial record (NCT05842824)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

TARGET-AUTOIMMUNE is an observational research study to conduct a comprehensive review of outcomes for patients with autoimmune and related diseases. .

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2023-04-24; most recent amendment 2024-11-18.

Trial Details

NCT Number	NCT05842824
Lead Sponsor	Target PharmaSolutions, Inc.
Conditions	Autoimmune Diseases
Enrollment	500,000 participants
Start Date	2025-03-31
Primary Completion	2038-12-31 (estimated)
Study Completion	2038-12-31 (estimated)
Updated on ClinicalTrials.gov	2024-11-20